Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — White House Noncommittal Regarding Implementation of Biden’s Marijuana Campaign Promises

President Joseph Biden has stood by most of the infrastructure promises he made during his campaign in 2020, passing a massive infrastructure bill a few months after he took office that would invest billions of dollars into building American infrastructure. However, infrastructure wasn’t the only thing Biden talked about during his campaigns. The president also ran his campaign platform on cannabis reform, stating that although he wasn’t a fan of full legalization, he supported medical cannabis and the rights of states to determine their own cannabis laws.

However, nearly two years after Biden assumed office, his administration still hasn’t acted on the bulk of cannabis promises he made during his campaign. Over the past year, stakeholders in the cannabis industry, lawmakers and reform activists have grown increasingly irritated at the administration’s inaction, with a group of senators recently calling on Biden to issue a blanket pardon for people with low-level cannabis offenses.

During a recent briefing, White House Press Secretary Karine Jean-Pierre said that even though Biden has expressed support for modest cannabis reform, his administration does not have “anything to announce” regarding whether the president will fulfill his campaign marijuana promises. The press secretary was responding to a remark about a statement from Pennsylvania Lt. Gov. John Fetterman, who called on Biden to fulfill his promise to decriminalize cannabis.

A representative from the lieutenant governor had said that Fetterman looks forward to discussing the need for marijuana decriminalization with Biden at the upcoming Labor Day Parade in Pittsburgh. Although the press secretary didn’t respond directly to Fetterman’s comment about the need to decriminalize cannabis at the federal level, she said that the president is committed to issuing “evidence-based policies” and is focused on dealing with the “addiction and overdose epidemic.”

She mentioned that he still believes people should not be jailed for nonviolent cannabis offenses, pointing out the clemency actions he took in April when he commuted the sentences of 75 people, some of whom had nonviolent cannabis convictions on their records. Jean-Pierre added that she didn’t have a specific update to share on Biden’s plans to issue mass pardons for people with cannabis convictions or pass federal cannabis reform.

The press secretary noted that Biden still supported allowing states to determine their own recreational cannabis policies, rescheduling marijuana as a Schedule II drug to facilitate research into its risks and benefits, decriminalization at the federal level and automatically expunging nonviolent cannabis offenses.

If the Biden administration would enact even modest reforms at the federal level, such as decriminalizing medical marijuana, many believe that many opportunities would open up for cannabis industry companies, including ancillary ones such as Advanced Container Technologies Inc. (OTC: ACTX)  given that most states have legalized cannabis in some form.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New Survey Reports More Americans Using Cannabis Instead of Tobacco

New data from a Gallup survey shows that more Americans now smoke marijuana or consume marijuana-infused edibles than smoke cigarettes. This is despite the fact that the possession of cannabis is still prohibited federally and is even punishable by jail time in a number of states while the use of tobacco is legal.

We have seen trends in the use of tobacco and marijuana move in this direction over the last decade, as more states legalized the recreational and/or medical use of cannabis.

Gallup carried out the survey last month, finding that about 16% of individuals in America smoked marijuana. This is higher than the number of individuals who revealed that they’d smoked a cigarette in the last week, which stood at 11%.

For the first time, Gallup also asked participants whether they consumed marijuana edibles, finding that about 14% did. This means that more individuals eat or smoke federally illegal marijuana than those who smoke legal cigarettes.

The figures reported are also higher than the 2013 data on cannabis use, which stood at 7%. During that year, the use of cigarettes was 20%, which is higher than these latest figures but lower than the 45% recorded in the 1950s.

Despite increase in the use of marijuana, alcohol is still the most commonly used recreational substance in America. Some 45% of the survey’s respondents revealed that they had had alcohol in the last week, with 67% admitting that they occasionally used alcohol.

The survey also found that most Americans believed that cannabis had a positive impact on consumers and society at large, in comparison to alcohol.

These results are consistent with findings from a separate poll released earlier in the year, which found that a notable number of Americans thought that it would be good if more individuals drank less alcohol and instead switched to marijuana.

These results differ from a previous survey conducted in 2020, which indicated that more than 85% of Americans viewed alcohol as morally acceptable in comparison to the 70% who had the same view about cannabis consumption.

It is expected that the consumption of marijuana will continue to rise as the years go by, based on the trends observed in its usage as well as the fact that individuals generally perceive the use of marijuana is less harmful.

Growing public support to put an end to prohibition and the spread of the legalization movement across states in the country will also work in the trend’s favor.

The increasing number of people consuming marijuana products explains why so many companies, including American Cannabis Partners, are finding success in the markets in which they operate.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Announces Acquisition of Emerging Hemp Flower Market Brand

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced that its wholly owned subsidiary, Just Brands LLC, has acquired substantially all of the assets related to the No Cap Hemp Co. brand. The company anticipates that the acquisition of this emerging brand in the hemp flower market will diversify its brand portfolio and product offerings as well as create an opportunity to expand Flora’s distribution foothold in the United States by providing a unique collection of products with strong revenue growth potential. According to the announcement, the acquisition will offer Flora an immediate revenue stream as well as enhanced manufacturing capabilities. The asset acquisition calls for Flora to pay 10% of the gross revenue received from the sale of No Cap products up to a maximum of $2 million. “This transaction will allow Flora to immediately benefit from a profitable, cash flow positive and growing business,” said Flora Growth CEO and chair Luis Merchan in the press release. “This strategic acquisition demonstrates our disciplined capital allocation approach that is consistent with both short-term needs and long-term vision as a leading global cannabis company. We look forward to increasing our product offering through this transaction while broadening our sales team in the process.”

To view the full press release, visit https://cnw.fm/mdwv2

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New York Gives Ex-Convicts First Shot at Opening Recreational Cannabis Businesses

Historically, cannabis has been one of the most criminalized drugs in America. Thanks to the drug war, people who ran afoul of federal cannabis law were policed harshly by law enforcement and given extremely harsh sentences, especially people of color. In fact, research has shown that there is a clear bias in applying cannabis laws, with Black people being four times more likely to be arrested for cannabis use despite near identical use rates with White people.

Now that the war on drugs has been declared an unmitigated failure, and dozens of states across the U.S. are legalizing cannabis, many reform activists and lawmakers believe that social equity and justice should be a core aspect of the growing cannabis industry. They argue that it is inherently unjust for businesses to profit off of cannabis when tons of people had their lives ruined by relatively minor nonviolent convictions, with some of them still incarcerated for these offenses.

In New York, individuals who were convicted of cannabis offenses will have the first crack at the state’s incoming recreational cannabis industry. Of the 19 states that have legalized recreational cannabis, New York will be the first to solely offer the first cannabis dispensary licenses to entrepreneurs with cannabis convictions on their records. Like most cannabis social-equity provisions, this approach is designed to give Black and Brown communities that were disproportionately affected by the drug war a leg up in the multibillion dollar cannabis industry.

Having a criminal record in America can essentially prevent you from participating in society. A record makes it extremely difficult to obtain employment, housing, federal student aid, professional licenses and firearms. According to the executive director of New York’s Office of Cannabis Management, the state is looking to give people who have gone through “significant challenges” due to cannabis convictions a chance to open and operate successful businesses in the cannabis industry.

Other states with adult-use cannabis programs gave existing medical dispensaries the first chance to roll out recreational cannabis, which only gave big operators a chance to get even bigger. And even though places such as Detroit and Illinois used restrictions or lotteries to promote social equity in licensing, these processes are still engulfed in legislative fixes and legal challenges several years later.

New York will avoid this by issuing its first Conditional Adult Retail-Use Dispensary Licenses to New Yorkers with prior cannabis convictions. Successful applicants will be set up with financing and a retail location by the state to help them develop their recreational cannabis businesses. These locations could open their doors to the public by the end of the year.

The marijuana industry and established actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) have always believed that legalizing the substance would pave the way for redressing some of the social equity issues observed in the way prohibition laws were enforced. The steps being taken in New York are proof that it is possible to right those wrongs through designing the right legalization policies or laws.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Industry Moves to Become More Sustainable

Cannabis in America is estimated to be worth anywhere $28 billion in 2021 to roughly $197 billion currently as more states and the federal government are expected to legalize marijuana. However, the cannabis industry is often associated with a negative environmental impact.

Indoor cannabis grows tend to consume a lot of energy because of their heating and cooling needs; cannabis plants require a lot of water, and they often emit aromatic compounds. The cannabis industry has also been criticized for generating a lot of waste, including plastic and paper consumer packaging as well as electronic waste from vapes.

Even so, the sector is still keen on becoming more sustainable.

Sustainable Cannabis Coalition, which was founded by cannabis cultivation and manufacturing experts from North Carolina, promotes best practices associated with environmental stability in marijuana cultivation and manufacturing. The coalition supports academic research into cannabis sustainability and works with international bodies that set standards, managing to persuade ASTM International to establish a cannabis sustainability subcommittee. Sustainable Cannabis Coalition cofounder Shawn Cooney, who currently chairs the panel, said that the subcommittee hopes to vote on cannabis standards early next year.

The group also promotes software solutions that make it possible for cultivators to easily monitor their energy consumption, waste generation, and other environmental impacts of cultivating and manufacturing cannabis.

Operators are aware that indoor grows aren’t the most sustainable way to grow cannabis, even though it results in higher-quality products, and they are trying to find ways to limit their energy use without compromising product quality. Switching to LED lights has allowed some cultivators to reduce their energy use, with Smokey’s Cannabis chief operating officer and chief financial officer Melinda Jadinger stating that the company’s dedicated LED lights grow room produced the highest-quality and quantity of cannabis.

Native Roots, a Colorado-based cannabis producer, has deployed thousands of LED lights that have cut its power use by half; in addition, the lights last five times longer than T5 bulbs used in both Native Roots Denver facilities. The company also uses high-pressure sodium lights as part of its heating strategy, which reduces its heating costs by taking advantage of the heat that would have otherwise been seen as a nuisance.

The Sustainable Cannabis Coalition has also funded a project at Dartmouth College to find ways for cannabis cultivation facilities to cut their energy use without having to switch to LED lights.

Addressing excessive water use in the industry is also a key issue. Although data shows that water consumption in the cannabis industry pales in comparison to other agricultural commodities such as wine, wheat and vegetables, the industry has room for improvement. A significant level of water use is actually driven by the illicit industry, which is estimated to use a mind-boggling 11.4 million to 36.3 million liters of water per day.

More cannabis facilities are adopting drip irrigation systems and moving away from hand watering, which makes it much easier to avoid overwatering and conserve water, with some cultivators even deploying sensors to monitor moisture levels.

These and many other adaptations are helping cannabis companies such as Prime Harvest Inc. to make their operations as eco-friendly as possible, given the growing trend of consumers scrutinizing the ESG practices of the company from which they buy products.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Collaborates to Provide Healthy Food for Hungry Americans

Advanced Container Technologies (OTC: ACTX) today announced that it has partnered with the Clean Food Initiative and Produce Now to provide fresh, healthy food to disadvantaged youth. According to the update, ACTX will allocate space in one or more of its GrowPods to grow leafy greens, which will be donated to the Clean Food Initiative for distribution to various hunger-related charities. Workers from Produce Now will grow, package and distribute the food. The Food Research and Action Center indicates that over 38 million Americans live in households that struggle with food insecurity or lack of access to an affordable, nutritious diet, representing a 9% increase from 2019. “This is a problem we just cannot turn our back on,” said Douglas Heldoorn, CEO of Advanced Container Technologies. “There are hungry people in towns throughout America. These are our neighbors, our sisters and brothers. We have a moral obligation to help those in need.”

To view the full press release, visit https://cnw.fm/ERipM

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Quest to Find Hypertension Treatment Promising With DehydraTECH(TM)’s Ability to Boost Bioavailability

  • Lexaria, a global innovator of drug delivery platforms is looking to provide a FDA registered hypertension treatment with its patented DehydraTECH technology
  • The company’s efforts are encapsulated in its DehydraTECH-CBD that has been shown to lower blood pressure as well as reduce arterial stiffness
  • Although hypertension is a devastating condition that can cause not only life-threatening illnesses but also death, only about 53% of Americans with the condition have it under control
  • A Harvard Health article notes that the remaining portion (47%) are not able to control the disease because they are discouraged by medications’ side effects
  • Lexaria’s DehydraTECH-CBD may well be the solution such individuals seek, but for now, the company is following the regulatory pathway to eventual drug approval

Hypertension causes life-threatening conditions such as stroke, heart attacks, coronary artery disease, and heart failure. But even more concerning, the condition leads to death. In 2020, the U.S. Center for Disease Control (“CDC”) reported that high blood pressure claimed more than 670,000 lives in the U.S. (https://cnw.fm/1PKhk). Globally, hypertension claims an estimated 7.5 million lives annually, according to the World Health Organization (“WHO”) (https://cnw.fm/UCJeh).

Despite these devastating consequences and statistics, only about half (53%) of Americans living with high blood pressure have it under control, a problem that a Harvard Health article attributes to, among other common reasons, the fact that many stop taking their medication citing side effects (https://cnw.fm/PyIVN).

As a result, scientists and researchers have continuously explored ways to increase the chances of success as regards having the condition under control. One such study, a clinical trial, employed “a new strategy where patients are started on a pill containing four medicines, each at a quarter of their usual doses. [The strategy] has been shown to be much more effective in getting blood pressure under control, compared to the common practice of monotherapy, where treatment commences with just one drug” (https://cnw.fm/hIzEK).

For researchers and scientists at Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, their quest takes a different approach that combines the effectiveness of the company’s proprietary DehydraTECH(TM) drug delivery technology and the emerging benefits of cannabidiol (“CBD”), one of which is the substance’s ability to slow down the heart rate and blood pressure, particularly in stressful situations (https://cnw.fm/3zQRf). In the latest tests, DehydraTECH-CBD has undergone human evaluations, yielding promising results.

CBD lowers systolic blood pressure in isolation (https://cnw.fm/bmz4O). However, with the addition of DehydraTECH, its capability and performance are boosted even further (https://cnw.fm/i311C). This is chiefly because DehydraTECH increases CBD’s bioavailability, a term that refers to the percentage of a drug that enters the bloodstream and becomes available to the intended biological target. In its first human study, conducted in 2018 and involving 12 patients, Lexaria showed that DehydraTECH delivered 317% more CBD to the bloodstream 30 minutes after ingestion (https://cnw.fm/E8e8K).

Since then, the company has undertaken a series of other human studies. 2021, in particular, saw the company complete three studies: HYPER-H21-1, HYPER-H21-2, and HYPER-H21-3. The first study evidenced a rapid and sustained decrease in blood pressure, particularly systolic pressure. The second study showed that DehydraTECH-CBD caused a 23% average reduction in overnight blood pressure in addition to reducing arterial stiffness. The third revealed that the substance caused a 41% overall attenuation in pulmonary artery systolic pressure among male participants.

Its fourth study, HYPER-H21-4, is its most comprehensive yet. With dosing having been completed in late July, Lexaria announced that no serious adverse events were reported. “Demonstrating a noteworthy safety and tolerability profile relative to conventional anti-hypertensive medications is one of Lexaria’s major goals with this program, and avoiding serious adverse events at clinically efficacious doses will be a primary requirement to achieve eventual regulatory marketing authorization,” Lexaria CEO Chris Bunka said of the HYPER-H21-4 study (https://cnw.fm/qqtZb).

The company looks to leverage the results of the fourth study to file an Investigational New Drug (“IND”) application seeking the U.S. Food and Drug Administration (“FDA”)’s approval to begin registered clinical testing at Phase I level or higher. The study, Lexaria observes, is designed to boost the company’s probability of success with the application.

And as analysis contained in an August 11 press release shows, the commencement of Phase I (or even higher) studies, as and when it happens, could portend good tidings for the company’s investors. According to a valuation guide authored by Bay Bridge Bio, the potential valuation of a company increases as a company’s clinical trials move from Phase I through Phase III. Accordingly, Lexaria’s valuation may trend upward with time (https://cnw.fm/mjpxT).

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Improvements in Marijuana Genetics Boosting Profits, Protecting the Environment

Despite the medical and economic benefits that come with cannabis reform, marijuana cultivation can be extremely hard on the environment. Cultivating the substance requires a ton of energy for heating and cooling, consumes gallons upon gallons of water, and is often associated with an increased number of airborne pollutants. Furthermore, the pesticides used to keep pests and diseases away from cannabis grows can leach into the ground and contaminate the soil.

With the cannabis industry poised to be worth $197.74 billion by 2028, regulators and stakeholders are looking for ways to reduce the environmental impact of cannabis cultivation. Improving marijuana genetics has emerged as a means of not only protecting the environment but also increasing profits within the nascent cannabis industry.

Thanks to advances in technology and science, it is now possible for cultivars to tweak cannabis genetics and make them more resistant to fungus and common pests, ultimately reducing cultivation inputs and increasing yields.

Although the illicit market has made significant advancements in increasing cannabis potency, little has been done to make cannabis more resistant to pests and fungi. As a result, growers have to practice extreme vigilance and invest in expensive pesticides, which could contaminate the end product and damage the environment.

Fortunately, the industry is becoming home to cleaner cannabis products, both in terms of product quality and environmental impact, due to new research and scientific breakthroughs that are aimed at eliminating the use of dangerous chemicals in the management of pests and diseases.

Improvements in cannabis genetics will make marijuana plants more resistant to pests and diseases. This will in turn reduce the number of pesticides and fungicides growers use on their plants and limit pesticide and fungicide contamination that impact consumers and the environment.

These advancements will also make plants hardier, meaning growers will be less likely to lose their entire crop due to pest and disease infestation or pesticide contamination. Companies will also spend less on staff to constantly monitor the plants, a cost that can be prohibitively expensive depending on the size of the operation.

Cumulatively, the result will be pest- and disease-resistant cannabis plants that are more likely to produce higher yields, thereby also producing higher profits while also reducing employee costs, which increases profit margins even further. Additionally, these advancements in marijuana genetics will reduce the impact of cannabis cultivation on the environment by reducing fertilizer and pesticide use.

Researchers will also be able to develop cannabis genetics that can function in different climates, a feat that will allow growers to stay profitable as the climate becomes increasingly unpredictable.

This stability is critical if established industry companies such as Flora Growth Corp. (NASDAQ: FLGC) are to keep their products competitively priced and attract even more consumers at a time when costs of production are spiraling around the world.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Research into Medical Benefits of Marijuana Is Growing

Decades of federal prohibition, intense policing and harsh sentencing made it virtually impossible for researchers to study the possible effects and risks of cannabis consumption. But over the past 20 years or so, loosening marijuana policies across the country have made it possible for scientists to finally study cannabis. Anecdotal reports coupled with initial studies have revealed that cannabis has plenty of medical potential, leading to a slew of states legalizing medical cannabis.

More than 25 years after California first legalized medical cannabis, researchers are still delving into the controversial plant. There’s still a lot that we don’t know about cannabis, including how long-term consumption can affect users; this is primarily due to restrictions placed on cannabis research by the federal government.

Most of our scientific data on cannabis comes from a handful of studies that were mostly carried out by pharmaceutical companies, universities and other entities, with a significant percentage of the funding for these studies coming from the National Institutes of Health and the National Institute on Drug Abuse.

In recent months, however, the U.S. Drug Enforcement Administration (DEA) has expanded the number of entities that are federally allowed to research cannabis from one to six. The DEA has also issued cannabis research licenses to entities interested in delving deeper into marijuana’s properties and effects and has even awarded licenses to companies with state-level marijuana retail licenses, including MedPharma Holdings in Colorado.

The cannabis research field has also seen a slight increase in federal funding opportunities, with one Connecticut-based firm, CT Pharma,  managing to snag federal approval for a partnership that would see it supply cannabis to Yale University for research purposes. The segment is also expected to see an infusion of federal funding due to a provision in last year’s $1 trillion federal infrastructure bill, which allows researchers to use cannabis from state-licensed retail businesses in their studies.

Surprisingly, plenty of federally sanctioned marijuana growers and researchers say that the Food and Drug Administration (FDA) has been quite supportive. In a prior interview with MJBizDaily, MedPharma CEO Albert Gutierrez said that working with the DEA has been quite good, stating that while the federal agencies can be slow, they are responsive. Scottsdale Research Institute’s Dr. Sue Sisley also noted the company’s great working relationship with the DEA, saying that the agency has been a collaborative supporter in the decade and a half since it began working with the institute.

Attitudes in the scientific, medical and pharmaceutical industries are shifting in favor of cannabis research, with millions of dollars being invested in medical marijuana research. There are an increasing number of studies looking into cannabis’ impact on ailments such as sleep problems, brain inflammation, opiate replacement and pain management. We can expect to see even more cannabis research in the coming years if lawmakers pass federal cannabis legislation and remove the existing restrictions on research.

As those restrictions are eased, it could get a little easier for sector players such as American Cannabis Partners to conduct the requisite research in the course of coming up with innovative products to suit the changing dynamics of the marijuana market.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced an addition to its board of directors; the company named industry veteran Catherine Turkel, PharmD, PhD, as the newest member of its board. Turkel brings more than two decades of experience as an executive-level leader in both start-up and mid-size pharma/biotech companies. As founder and CEO of Nezee Therapeutics, she gained critical expertise and insight in the space; she also served as president and head of research and development Novus Therapeutics, which was later renamed Eledon Pharmaceuticals Inc. (NASDAQ: ELDN). Currently she serves as an independent board director at Object Pharma and advisory committee member at nonprofit Prostate Cancer Research; she is also a dean advisor at Chapman University School of Pharmacy. In her various roles, Turkey has led and executed FDA registration and commercial strategic plans as well as global development programs; she has invaluable experience in a range of sectors, including neurosciences, pain, cardiovascular, psychiatry, rare diseases, ophthalmology, aesthetics, urology and otology therapeutic areas. In addition, Turkel designed and led an innovative BOTOX(R) chronic migraine registration program for Allergan, now AbbVie Inc. (NYSE: ABBV), which generated more than a billion dollars. “Lexaria is delighted to welcome Dr. Turkel as we continue to position the company for advancement following our recent successful pre-IND meeting with the Food and Drug Administration,” said Lexaria board chair Chris Bunka in the press release. “Catherine’s practical development and regulatory expertise will be of increasing value to Lexaria, and we look forward to working with her.”

To view the full press release, visit https://cnw.fm/JroKp

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com. 

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.